Literature DB >> 1464878

Cognitive-behavioral intervention for juvenile primary fibromyalgia syndrome.

G A Walco1, N T Ilowite.   

Abstract

Seven girls between 8.6 and 17.7 years of age were treated for symptoms of juvenile primary fibromyalgia syndrome (JPFS) using cognitive-behavioral techniques (progressive muscle relaxation, guided imagery) aimed at reducing pain and facilitating sleep, as well as strategies aimed at increasing mastery over the pain and improving mood. Patients satisfying diagnostic criteria for JPFS based on the presence of chronic diffuse musculoskeletal pain lasting at least 3 months (mean = 9.4, SD = 8.28) and a minimum of 5 characteristic soft tissue trigger and/or tender points with absence of synovitis, were referred for intervention. Results indicated that in the majority of patients, such techniques were effective in reducing pain and facilitating improved functioning.

Entities:  

Mesh:

Year:  1992        PMID: 1464878

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

1.  Chronic musculoskeletal and other idiopathic pain syndromes.

Authors:  P N Malleson; H Connell; S M Bennett; C Eccleston
Journal:  Arch Dis Child       Date:  2001-03       Impact factor: 3.791

2.  Family cognitive behaviour therapy for chronic fatigue syndrome: an uncontrolled study.

Authors:  T Chalder; J Tong; V Deary
Journal:  Arch Dis Child       Date:  2002-02       Impact factor: 3.791

3.  Long-term outcomes of adolescents with juvenile-onset fibromyalgia in early adulthood.

Authors:  Susmita Kashikar-Zuck; Natoshia Cunningham; Soumitri Sil; Maggie H Bromberg; Anne M Lynch-Jordan; Daniel Strotman; James Peugh; Jennie Noll; Tracy V Ting; Scott W Powers; Daniel J Lovell; Lesley M Arnold
Journal:  Pediatrics       Date:  2014-02-24       Impact factor: 7.124

4.  Recent developments in the understanding of paediatric musculoskeletal pain syndromes.

Authors:  T R Southwood
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

5.  The Role of Salivary Neuropeptides in Pediatrics: Potential Biomarkers for Integrated Therapies.

Authors:  Lynn A Gershan; Paul L Durham; Jaci Skidmore; Joshua Shimizu; Ryan J Cady; Xiaoming Sheng; Christopher G Maloney
Journal:  Eur J Integr Med       Date:  2015-08       Impact factor: 1.314

6.  Joint hypermobility and fibromyalgia in schoolchildren.

Authors:  A Gedalia; J Press; M Klein; D Buskila
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

Review 7.  Nonpharmacologic treatment for fibromyalgia: patient education, cognitive-behavioral therapy, relaxation techniques, and complementary and alternative medicine.

Authors:  Afton L Hassett; Richard N Gevirtz
Journal:  Rheum Dis Clin North Am       Date:  2009-05       Impact factor: 2.670

8.  Fibromyalgia and chronic fatigue syndrome: an update for athletic trainers.

Authors:  C R Cramer
Journal:  J Athl Train       Date:  1998-10       Impact factor: 2.860

9.  Cognitive-behavioral therapy for physical and emotional disturbances in adolescents with polycystic ovary syndrome: a pilot study.

Authors:  Dana L Rofey; Eva M Szigethy; Robert B Noll; Ronald E Dahl; Emily Lobst; Silva A Arslanian
Journal:  J Pediatr Psychol       Date:  2008-06-12

Review 10.  [Psychosomatic aspects in the diagnosis and treatment of fibromyalgia].

Authors:  K Blumenstiel; W Eich
Journal:  Schmerz       Date:  2003-12       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.